The effect of aminoglycoside antibiotics (amikacin, gentamicin, netilmicin and tobramycin) at sublethal concentrations (sub-MICs) on some properties of Plesiomonas shigelloides strains was evaluated. All agents decreased the bacterial surface hydrophobicity. Amikacin (1/4 of the MIC) and netilmicin (1/4 and 1/8 of the MIC) changed the hydrophobic character of P. shigelloides surface to a hydrophilic one. Treatment of the strains with aminoglycosides decreased also motility, netilmicin being the most effective. No significant changes were found in lipolytic activity of antibiotic-treated strains. In the majority of cases aminoglycosides increased sensitivity of bacteria to hydrogen peroxide. The tested antibiotics did not induce production of short-chained N-acylhomoserine lactones signal molecules. Aminoglycosides at sub-MICs affected important activities of P. shigelloides potentially associated with their virulence in dependence on strain, antibiotic and concentration.

Institute of Preventive and Clinical Medicine 833 01 Bratislava Slovakia

See more in PubMed

Microbios. 1997;91(368-369):137-43 PubMed

Antimicrob Agents Chemother. 1990 Jan;34(1):159-60 PubMed

Antimicrob Agents Chemother. 1988 Aug;32(8):1247-50 PubMed

J Antimicrob Chemother. 2000 Jan;45(1):15-25 PubMed

Cent Eur J Public Health. 1999 Feb;7(1):47-9 PubMed

Comp Immunol Microbiol Infect Dis. 2000 Jan;23(1):45-51 PubMed

Microbiol Rev. 1996 Mar;60(1):167-215 PubMed

Pediatr Infect Dis J. 2001 Dec;20(12):1178-9 PubMed

Microbios. 1996;87(350):21-30 PubMed

Microb Pathog. 1988 Sep;5(3):207-13 PubMed

Folia Microbiol (Praha). 2001;46(6):505-10 PubMed

Hong Kong Med J. 2000 Dec;6(4):375-80 PubMed

Infect Immun. 2001 Apr;69(4):2260-9 PubMed

Folia Microbiol (Praha). 2000;45(6):485-90 PubMed

Epidemiol Infect. 2000 Dec;125(3):523-30 PubMed

J Bacteriol. 1998 Mar;180(6):1402-10 PubMed

Rev Infect Dis. 1988 Mar-Apr;10(2):303-16 PubMed

Folia Microbiol (Praha). 1999;44(6):587-624 PubMed

Antimicrob Agents Chemother. 1989 Jan;33(1):41-7 PubMed

Scand J Infect Dis. 1995;27(5):495-8 PubMed

J Clin Microbiol. 1988 Jul;26(7):1343-8 PubMed

Annu Rev Microbiol. 1988;42:395-419 PubMed

J Antimicrob Chemother. 1994 Dec;34(6):931-42 PubMed

J Antimicrob Chemother. 1993 May;31(5):681-8 PubMed

Folia Microbiol (Praha). 2000;45(5):387-90 PubMed

Comp Immunol Microbiol Infect Dis. 2001 Jan;24(1):39-55 PubMed

J Microbiol Methods. 2001 Apr;44(3):239-51 PubMed

J Clin Microbiol. 1988 May;26(5):979-84 PubMed

J Antimicrob Chemother. 2000 Jun;45(6):877-80 PubMed

J Hyg (Lond). 1980 Apr;84(2):203-11 PubMed

J Microbiol Immunol Infect. 2002 Mar;35(1):47-52 PubMed

Curr Opin Microbiol. 1999 Apr;2(2):188-94 PubMed

J Clin Microbiol. 1993 May;31(5):1206-8 PubMed

Acta Pathol Microbiol Scand. 1968;72(2):263-76 PubMed

Antimicrob Agents Chemother. 1993 Apr;37(4):675-80 PubMed

J Bacteriol. 1995 Nov;177(22):6330-7 PubMed

J Gen Microbiol. 1988 Jan;134(1):43-52 PubMed

J Antimicrob Chemother. 2001 Dec;48(6):803-11 PubMed

Influence of subinhibitory concentrations of amikacin and ciprofloxacin on morphology and adherence ability of uropathogenic strains

Potential virulence-associated properties of Plesiomonas shigelloides strains